Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Open-label Study to Compare the Tolerability Between Rivastigmine Patch Monotherapy and Combination Therapy With Memantine in Patients With Alzheimer's Disease

NCT01025466 is registered in ClinicalTrials.gov with Inha University Hospital as lead sponsor.

NCT NCT01025466
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01025466 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Open-label Study to Compare the Tolerability Between Rivastigmine Patch Monotherapy and Combination Therapy With Memantine in Patients With Alzheimer's Disease
Lead sponsor
Inha University Hospital
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2008
Completion date
April 30, 2010
Enrollment
206 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease